CHIC HPV Council Consensus Statement on One-Dose Recommendation

In this consensus statement dated April 28, 2022, the CHIC HPV Council welcomes the WHO SAGE conclusion that a single-dose HPV vaccine delivers solid protection comparable to two- or three-dose schedules, and urges national immunization programmes and policy bodies to act on this recommendation. The Council highlights benefits for girls and families (comparable protection), programme […]

Déclaration de consensus du Conseil de CHIC sur le VPH

Dans cette déclaration de consensus datée du 28 avril 2022, le Conseil HPV du CHIC accueille favorablement la conclusion du SAGE de l’OMS selon laquelle un vaccin anti-papillomavirus à dose unique confère une protection solide, comparable à un schéma à deux ou trois doses, et appelle les programmes nationaux de vaccination et les organes consultatifs […]

CHIC: Coalition to Strengthen the HPV Immunization Community – Briefing on HPV and Vaccination

This CHIC briefing document provides a concise overview of HPV disease burden, vaccination programmes, and key challenges facing low- and middle-income countries. It describes HPV as the most common sexually transmitted infection globally, responsible for over 630,000 new cancer cases and 311,000 deaths annually, with 530,000 being cervical cancers. The brief highlights that over 85% […]

Impact Brief: Strengthening HPV Immunization: Community and Learning through CHIC

This CHIC legacy brief documents the initiative’s impact across five regional symposia held since 2022 in sub-Saharan Africa, Francophone Africa, South Asia, and Southeast Asia/Western Pacific, engaging over 600 stakeholders from 46 countries. By prioritizing country-led presentations and cross-country peer learning over expert lectures, CHIC has created sustained platforms for EPI managers, researchers, and policymakers […]

>